Researchers have uncovered a new way to attack lymphoma by targeting a non-catalytic region of a key regulatory enzyme, rather than its traditional active site. Researchers at VCU Massey Comprehensive ...

Understand how childhood and adult lymphoma differ in causes, symptoms, diagnosis, treatment options, and survival rates to improve awareness and early detection.

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

Germany's Bayer has faced thousands of lawsuits after buying Roundup maker Monsanto in 2018 for $63 billion.

Nodular sclerosis Hodgkin lymphoma is the most common subtype. It often starts in lymph nodes in the chest or neck and is ...

A new UNC study finds that a chemical derived from ashwagandha disrupts viral and cancer processes that make B-cell lymphomas difficult to treat with standard chemotherapy. Cancer has many causes, ...

The FDA has removed R/R PCNSL from a Limitations of Use section on the CAR-T product’s label based on positive findings from ...

BOSTON -- Researchers at the National Institutes of Health found a new treatment for lymphoma that is not chemotherapy. The recent study focused on a non-chemotherapy treatment for people with ...

The FDA has approved a label update for axicabtagene ciloleucel (axi-cel; Yescarta), a CD19-directed autologous T-cell ...

Aleksandra Smith of Millstone prided herself on her blonde hair. But the way she approached losing that typifies how she ...

Discover how Laverdia CA1 (verdinexor) treats canine lymphoma. Learn about the mechanism of action, handling precautions, and ...